Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP775323.RAH1Xht9vx71BmZqf2hbheksaPQ5XVPM2-2QkVJp9K-bg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP775323.RAH1Xht9vx71BmZqf2hbheksaPQ5XVPM2-2QkVJp9K-bg130_assertion type Assertion NP775323.RAH1Xht9vx71BmZqf2hbheksaPQ5XVPM2-2QkVJp9K-bg130_head.
- NP775323.RAH1Xht9vx71BmZqf2hbheksaPQ5XVPM2-2QkVJp9K-bg130_assertion description "[Treatment of PEL-injected severe combined immunodeficiency mice with hIFN-alpha(2)b-LV significantly prolonged mice survival and reduced ascites development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775323.RAH1Xht9vx71BmZqf2hbheksaPQ5XVPM2-2QkVJp9K-bg130_provenance.
- NP775323.RAH1Xht9vx71BmZqf2hbheksaPQ5XVPM2-2QkVJp9K-bg130_assertion evidence source_evidence_literature NP775323.RAH1Xht9vx71BmZqf2hbheksaPQ5XVPM2-2QkVJp9K-bg130_provenance.
- NP775323.RAH1Xht9vx71BmZqf2hbheksaPQ5XVPM2-2QkVJp9K-bg130_assertion SIO_000772 19196659 NP775323.RAH1Xht9vx71BmZqf2hbheksaPQ5XVPM2-2QkVJp9K-bg130_provenance.
- NP775323.RAH1Xht9vx71BmZqf2hbheksaPQ5XVPM2-2QkVJp9K-bg130_assertion wasDerivedFrom befree-20140225 NP775323.RAH1Xht9vx71BmZqf2hbheksaPQ5XVPM2-2QkVJp9K-bg130_provenance.
- NP775323.RAH1Xht9vx71BmZqf2hbheksaPQ5XVPM2-2QkVJp9K-bg130_assertion wasGeneratedBy ECO_0000203 NP775323.RAH1Xht9vx71BmZqf2hbheksaPQ5XVPM2-2QkVJp9K-bg130_provenance.